AUTOIMMUNE ENCEPHALITIS: DIAGNOSTIC AND TREATMENT APPROACH
DOI:
https://doi.org/10.21776/ub.mnj.2024.010.02.13Keywords:
autoimmune encephalitis, anti-NMDA-receptor encephalitis, neuropsychiatry, immunotherapyAbstract
Autoimmune encephalitis is a type of brain inflammation induced by an inappropriate immune response to a neuronal antigen, resulting in the generation of autoantibodies. Autoimmunity as important cause of encephalitis in recent years has not been much reported in Indonesia. Increased familiarity with autoimmune encephalitis among physician, not only neurologist, is extremely important for early detection. Prompt diagnosis and early immunotherapy leads to better prognosis in this potentially treatable disease, despite a long disease course. Autoimmune encephalitis is characterized by acute-subacute progressive neuropsychiatric symptoms with associated cognitive dysfunction, encephalopathy, psychiatric disorders, movement disorders and seizures, with anti-N-methyl-D-aspartate (NMDA) receptors encephalitis as the most common type. In addition to clinical features, further diagnostic investigations needed are brain magnetic resonance imaging (MRI), electroencephalography (EEG), cerebrospinal fluid (CSF) analysis, and autoantibody testing. Challenges in establishing diagnosis include wide range of clinical symptoms, absence of abnormalities in brain MRI, unspecified EEG findings, negative antibody testing, and limited availability of antibody testing in Indonesia. This literature review discusses the recognition, diagnosis and principle of treatment of autoimmune encephalitis.
Downloads
References
Patel A, Meng Y, Najjar A, Lado F, Najjar S. Autoimmune Encephalitis: A Physician’s Guide to the Clinical Spectrum Diagnosis and Management. Brain Sci [Internet; 2022. Sep 1 [cited 2023 Oct 11];12(9). Available from:
https://pubmed.ncbi.nlm.nih.gov/36138865/
Pearce JMS. Paraneoplastic Limbic Encephalitis. Eur Neurol [Internet]; 2005. 53:106–8. Available from: www.karger.com
Ellul MA, Wood G, van Den Tooren H, Easton A, Babu A, Michael BD. Update on the diagnosis and management of autoimmune encephalitis. Clinical Medicine [Internet]; 2020. Jul 1 [cited 2023 Oct 11];20(4):389.
Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis [Internet]; 2013. Oct 15 [cited 2023 Oct 11];57(8):1114–28. Available from: https://pubmed.ncbi.nlm.nih.gov/23861361/
Lancaster E. The Diagnosis and Treatment of Autoimmune Encephalitis. J Clin Neurol [Internet]; 2016. Jan 1 [cited 2023 Oct 11];12(1):1.
Abbatemarco JR, Yan C, Kunchok A, Rae-Grant A. Antibody-mediated autoimmune encephalitis: A practical approach. Cleve Clin J Med [Internet]; 2021. 88(8):459–71. Available from: https://pubmed.ncbi.nlm.nih.gov/34341030/
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry [Internet]; 2021. Jul 1 [cited 2023 Oct 11];92(7):757–68. Available from: https://pubmed.ncbi.nlm.nih.gov/33649022/
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol [Internet]; 2016. Apr 1 [cited 2023 Oct 11];15(4):391–404.
Available from:
https://pubmed.ncbi.nlm.nih.gov/2690696
Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmune encephalitis: A review of diagnosis and treatment. Arq Neuropsiquiatr [Internet]; 2018. Jan 1 [cited 2023 Oct 11];76(1):41–9. Available from:
https://pubmed.ncbi.nlm.nih.gov/29364393/
Simabukuro MM, da Silva GD, Castro LHM, Lucato LT. A critical review and update on autoimmune encephalitis: Understanding the alphabet soup. Arq Neuropsiquiatr [Internet]; 2022. May 1 [cited 2023 Oct 11];80(5 Suppl 1):143–58. Available from: https://pubmed.ncbi.nlm.nih.gov/35976312/
Uy CE, Binks S, Irani SR. Autoimmune encephalitis: Clinical spectrum and management. Pract Neurol [Internet]; 2021. Oct 1 [cited 2023 Oct 11];21(5):412.
Granerod J, Cousens S, Davies NWS, Crowcroft NS, Thomas SL. New estimates of incidence of encephalitis in England. Emerg Infect Dis [Internet]; 2013. Sep [cited 2023 Oct 11];19(9):1455.
Granerod J, Ambrose HE, Davies NWS, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study. Lancet Infect Dis [Internet]; 2010. Oct 15 [cited 2023 Oct 11];10(12):835–44. Available from: https://europepmc.org/article/med/20952256
Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol [Internet]; 2018. Jan 1 [cited 2023 Oct 11];83(1):166–77. Available from: https://europepmc.org/articles/PMC6011827
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis [Internet]; 2012. Apr 1 [cited 2023 Oct 11];54(7):899–904. Available from: https://pubmed.ncbi.nlm.nih.gov/22281844/
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: A cohort study. Lancet neurology [Internet]; 2013. Feb [cited 2023 Oct 11];12(2):157.
Hoang HE, Robinson-Papp J, Mu L, Thakur KT, Gofshteyn JS, Kim C, et al. Determining an infectious or autoimmune etiology in encephalitis. Ann Clin Transl Neurol [Internet]. 2022 Jun 17 [cited 2023 Oct 23];9(8):1125–35. Available from: https://europepmc.org/articles/PMC9380144
Huang CN, Tian XB, Jiang SM, Chang SH, Wang N, Liu MQ, et al. Comparisons Between Infectious and Autoimmune Encephalitis: Clinical Signs, Biochemistry, Blood Counts, and Imaging Findings. Neuropsychiatr Dis Treat [Internet]. 2020 [cited 2023 Oct 23];16:2649. Available from: /pmc/articles/PMC7649224/
Shin YW, Lee ST, Park K Il, Jung KH, Jung KY, Lee SK, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord [Internet]. 2018 Jan 1 [cited 2023 Oct 23];11. Available from: /pmc/articles/PMC5784571/
Nguyen L, Wang C. Anti-NMDA Receptor Autoimmune Encephalitis: Diagnosis and Management Strategies. Int J Gen Med [Internet]. 2023 [cited 2023 Oct 23];16:7–21. Available from: https://pubmed.ncbi.nlm.nih.gov/36628299/
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry [Internet]. 2021 Aug 1 [cited 2023 Oct 27];92(8):897–907. Available from: https://profiles.wustl.edu/en/publications/autoimmune-encephalitis-proposed-recommendations-for-symptomatic-
Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry [Internet]. 2020 Jan 1 [cited 2023 Oct 30];7(1):93–108. Available from: https://pubmed.ncbi.nlm.nih.gov/31669058/
Baizabal-Carvallo JF, Jankovic J. Autoimmune and paraneoplastic movement disorders: An update. J Neurol Sci [Internet]. 2018 Feb 15 [cited 2023 Oct 30];385:175–84. Available from: https://pubmed.ncbi.nlm.nih.gov/29406
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 MNJ (Malang Neurology Journal)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.